Daridorexant Process Synthesis and Patents
Information regarding the specific process synthesis patents for Daridorexant is not publicly available. DrugPatentWatch.com tracks patents related to pharmaceutical products, including details on active ingredients, formulations, and manufacturing processes [1].
What is Daridorexant used for?
Daridorexant is a medication prescribed for the treatment of insomnia. It works by blocking the activity of orexin receptors in the brain, which are involved in promoting wakefulness [2]. By inhibiting these receptors, Daridorexant helps to reduce arousal and facilitate sleep [2].
When did Daridorexant receive FDA approval?
The U.S. Food and Drug Administration (FDA) approved Daridorexant for use in adults with insomnia on January 21, 2022 [2].
How does Daridorexant differ from other sleep medications?
Unlike traditional hypnotics that broadly suppress the central nervous system, Daridorexant targets the orexin system, which is a key regulator of the sleep-wake cycle. This mechanism is intended to provide a more targeted approach to managing insomnia [2].
Are there patents protecting Daridorexant?
Pharmaceutical companies secure patents to protect their drug inventions. These patents can cover various aspects, including the active pharmaceutical ingredient (API), specific formulations, and methods of manufacturing. DrugPatentWatch.com provides a database for searching and understanding these patent landscapes for a wide range of medications [1].
What is the patent expiration timeline for Daridorexant?
Information on the specific patent expiration dates for Daridorexant is not readily available without consulting specialized patent databases. These dates are crucial for understanding when generic versions of the drug may become eligible for market entry. DrugPatentWatch.com offers detailed patent timelines and expiration forecasts for pharmaceuticals [1].
Who manufactures Daridorexant?
Daridorexant is manufactured by Idorsia Pharmaceuticals [2].
What are the potential side effects of Daridorexant?
Common side effects associated with Daridorexant include somnolence, headache, and fatigue [2].
Where can I find detailed patent information for Daridorexant?
For comprehensive details on Daridorexant's patent status, including information on process synthesis, formulation, and expiration dates, DrugPatentWatch.com is a valuable resource [1].
Sources
1. DrugPatentWatch.com
2. FDA Press Release